Newbury Pharmaceuticals AB (OSTO:NEWBRY) Additional Paid-In Capital : kr0.00 Mil(As of Feb. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Newbury Pharmaceuticals AB Additional Paid-In Capital?

Newbury Pharmaceuticals AB's quarterly additional paid-in capital declined from Aug. 2024 (kr106.72 Mil) to Nov. 2024 (kr0.00 Mil) but then stayed the same from Nov. 2024 (kr0.00 Mil) to Feb. 2025 (kr0.00 Mil).

Newbury Pharmaceuticals AB's annual additional paid-in capital stayed the same from Aug. 2022 (kr88.71 Mil) to Aug. 2023 (kr88.71 Mil) but then increased from Aug. 2023 (kr88.71 Mil) to Aug. 2024 (kr106.72 Mil).

Newbury Pharmaceuticals AB Additional Paid-In Capital Historical Data

The historical data trend for Newbury Pharmaceuticals AB's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Newbury Pharmaceuticals AB Additional Paid-In Capital Chart

Newbury Pharmaceuticals AB Annual Data

Trend

Aug21

Aug22

Aug23

Aug24

Additional Paid-In Capital

43.89

88.71

106.72

Newbury Pharmaceuticals AB Quarterly Data
	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25
Additional Paid-In Capital	Get a 7-Day Free Trial													-	-	106.72	-	-

Newbury Pharmaceuticals AB Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Newbury Pharmaceuticals AB Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Newbury Pharmaceuticals AB's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Newbury Pharmaceuticals AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Newbury Pharmaceuticals AB (OSTO:NEWBRY) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

Scheeletorget 1, Medicon Village, Lund, SWE, 223 81

Website

https://www.newburypharma.com

Newbury Pharmaceuticals AB is a hybrid pharmaceutical company for specialty prescription drugs, innovation and brands with focus on the Scandinavian markets.

Newbury Pharmaceuticals AB Headlines

No Headlines